These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10372688)

  • 1. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy.
    Yanovski JA; Miller KD; Kino T; Friedman TC; Chrousos GP; Tsigos C; Falloon J
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1925-31. PubMed ID: 10372688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
    Rietschel P; Hadigan C; Corcoran C; Stanley T; Neubauer G; Gertner J; Grinspoon S
    J Clin Endocrinol Metab; 2001 Feb; 86(2):504-10. PubMed ID: 11158000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of hypersensitivity to glucocorticoids in antiretroviral-associated lipodystrophy.
    Martin IP; Breen PA; Weigle DS
    Obes Res; 2003 Jan; 11(1):21-4. PubMed ID: 12529481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.
    Hadigan C; Miller K; Corcoran C; Anderson E; Basgoz N; Grinspoon S
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1932-7. PubMed ID: 10372689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.
    Petit JM; Duong M; Duvillard L; Piroth L; Grappin M; Verges B; Chavanet P; Brun JM; Portier H
    Horm Metab Res; 2000 Sep; 32(9):367-72. PubMed ID: 11014386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Buffalo hump" in men with HIV-1 infection.
    Lo JC; Mulligan K; Tai VW; Algren H; Schambelan M
    Lancet; 1998 Mar; 351(9106):867-70. PubMed ID: 9525364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children.
    Bitnun A; Sochett E; Dick PT; To T; Jefferies C; Babyn P; Forbes J; Read S; King SM
    J Clin Endocrinol Metab; 2005 Jan; 90(1):168-74. PubMed ID: 15483082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.
    Carr A; Samaras K; Thorisdottir A; Kaufmann GR; Chisholm DJ; Cooper DA
    Lancet; 1999 Jun; 353(9170):2093-9. PubMed ID: 10382692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.
    Martínez E; García-Viejo MA; Blanco JL; Bianchi L; Buira E; Conget I; Casamitjana R; Mallolas J; Gatell JM
    Clin Infect Dis; 2000 Nov; 31(5):1266-73. PubMed ID: 11073762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways.
    van der Valk M; Bisschop PH; Romijn JA; Ackermans MT; Lange JM; Endert E; Reiss P; Sauerwein HP
    AIDS; 2001 Nov; 15(16):2093-100. PubMed ID: 11684928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.
    Hadigan C; Corcoran C; Piecuch S; Rodriguez W; Grinspoon S
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3544-50. PubMed ID: 11061499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young south african adults: early programming of cortisol axis.
    Levitt NS; Lambert EV; Woods D; Hales CN; Andrew R; Seckl JR
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4611-8. PubMed ID: 11134116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
    Arrington-Sanders R; Hutton N; Siberry GK
    Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
    Hadigan C; Meigs JB; Corcoran C; Rietschel P; Piecuch S; Basgoz N; Davis B; Sax P; Stanley T; Wilson PW; D'Agostino RB; Grinspoon S
    Clin Infect Dis; 2001 Jan; 32(1):130-9. PubMed ID: 11118392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.
    Walli R; Herfort O; Michl GM; Demant T; Jäger H; Dieterle C; Bogner JR; Landgraf R; Goebel FD
    AIDS; 1998 Oct; 12(15):F167-73. PubMed ID: 9814858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.